Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory

INTRODUCTION: Immunotherapies have revolutionized the treatment of various cancers, but little is known about their symptomatic toxicity. Assessing these symptoms is best accomplished by asking the patients themselves. However, such reports are subjective and may face challenges as bonafide scientif...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Immunother Cancer
Autores principales: Mendoza, Tito, Sheshadri, Ajay, Altan, Mehmet, Hess, Kenneth, George, Goldy, Stephen, Bettzy, Castillo, Lilibeth, Rodriguez, Enedelia, Gong, Jing, Peterson, Christine, Rodon Ahnert, Jordi, Fu, Siqing, Piha-Paul, Sarina A, Pant, Shubham, Dumbrava, Ecaterina, Yap, Timonthy A, Janku, Filip, Tsimberidou, Apostolia M, Subbiah, Vivek, Karp, Daniel D, Zarifa, Abdulrazzak, McQuinn, Lacey M, Cleeland, Charles, Hong, David S, Naing, Aung
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590372/
https://ncbi.nlm.nih.gov/pubmed/33097611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000931
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares